Skip to main content
  • The Lecture Series Will Take Place on November 11th, 2025

    With speakers Moupali Das, MD, MPH “Lenacapavir for HIV Prevention: The PURPOSE Program”and Anu Osinusi MD, MPH “Viruses Don’t Wait: Innovation Across Virology”.

    READ MORE about The Lecture Series Will Take Place on November 11th, 2025
  • GHA

    University of Maryland School of Medicine Launches Global Health Alliance

    In an effort to strengthen its defenses against these budget cuts and build collaborations across its campus, the University of Maryland School of Medicine has formed a new partnership joining its global health leaders.

    READ NOW about University of Maryland School of Medicine Launches Global Health Alliance
  • 5th podcast

    We're Still Here: Or, How the Urban Indigenous Bridge Past and Present (PART I & II)

    What does it mean to be Indigenous in a modern American city? In this episode, we speak with Kerry Hawk Lessard, Executive Director of Native American Lifelines, about the deep and often-overlooked history of Baltimore’s Indigenous tribes.

  • Institute of Human Virology at International HBV Meeting

    The event also provided opportunities for early and mid-career researchers to strengthen professional communication skills, explore career development, and engage with leading experts in hepatitis B, hepatitis D, and liver cancer research.

    READ MORE about Institute of Human Virology at International HBV Meeting

Institute of Human Virology (IHV)

Research Initiatives

IHV BuildingIHV Research is Leading the Way Toward Innovative Therapies

IHV scientists and researchers are forging new paths in the fight against HIV and AIDS, the deadliest pandemic in modern medical history. The IHV is the first research institute in the U.S. to link basic science, population studies and clinical trials in an effort to develop new vaccines and treatments.

Patient Information

Doctor helping patient‌IHV is Providing Compassionate Cutting-Edge Care

The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV specializes in the treatment of HIV/AIDS and other chronic viral diseases, such as Hepatitis C, Hepatitis B, and the Human Papilloma Virus Infection.

News